WallStSmart

Next Technology Holding Inc (NXTT)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 2129% more annual revenue ($258.90M vs $11.61M). NXTT leads profitability with a 1233.0% profit margin vs -15.5%. NXTT earns a higher WallStSmart Score of 49/100 (D+).

NXTT

Hold

49

out of 100

Grade: D+

Growth: 4.7Profit: 6.0Value: 6.7Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for NXTT.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NXTT5 strengths · Avg: 10.0/10
P/E RatioValuation
0.0x10/10

Attractively priced relative to earnings

Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Return on EquityProfitability
53.3%10/10

Every $100 of equity generates 53 in profit

Profit MarginProfitability
1233.0%10/10

Keeps 1233 of every $100 in revenue as profit

Revenue GrowthGrowth
445.9%10/10

Revenue surging 445.9% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

NXTT4 concerns · Avg: 2.0/10
Market CapQuality
$118.97M3/10

Smaller company, higher risk/reward

EPS GrowthGrowth
-73.4%2/10

Earnings declined 73.4%

Free Cash FlowQuality
$-1.40M2/10

Negative free cash flow — burning cash

Operating MarginProfitability
-357.9%1/10

Operating margin of -357.9%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : NXTT

The strongest argument for NXTT centers on P/E Ratio, Price/Book, Return on Equity. Profitability is solid with margins at 1233.0% and operating margin at -357.9%. Revenue growth of 445.9% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : NXTT

The primary concerns for NXTT are Market Cap, EPS Growth, Free Cash Flow.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

NXTT profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

NXTT carries more volatility with a beta of 5.55 — expect wider price swings.

NXTT is growing revenue faster at 445.9% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NXTT scores higher overall (49/100 vs 41/100), backed by strong 1233.0% margins and 445.9% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Next Technology Holding Inc

TECHNOLOGY · SOFTWARE - APPLICATION · China

Next Technology Holding Inc. provides technical services and solutions through its social e-commerce platform primarily in Mainland China. The company is headquartered in Beijing, the People Republic of China.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?